Related Experiment Video
Updated: May 21, 2026

T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo
Published on: January 26, 2024
Isolation and characterization of a novel bacteriophage φ4D lytic against Enterococcus faecalis strains
Sylwia Parasion1, Magdalena Kwiatek, Lidia Mizak
1Military Institute of Hygiene and Epidemiology, Lubelska Str. 2, 24-100 Puławy, Poland. sparasion@gmail.com
Abstract:
In recent years, Enterococcus faecalis has emerged as an important opportunistic nosocomial pathogen capable of causing dangerous infections. Therefore, there is an urgent need to develop novel antibacterial agents to control this pathogen. Bacteriophages have very effective bactericidal activity and several advantages over other antimicrobial agents and so far, no serious or irreversible side effects of phage therapy have been described. The objective of this study was to characterize a novel virulent bacteriophage φ4D isolated from sewage. Electron microscopy revealed its resemblance to Myoviridae, with an isometric head (74 ± 4 nm) and a long contractile tail (164 ± 4 nm). The φ4D phage genome was tested using pulsed-field gel electrophoresis and estimated to be 145 ± 2 kb. It exhibited short latent period (25 min) and a relatively small burst size (36 PFU/cell). Tests were conducted on the host range, multiplicities of infection (MOI), thermal stability, digestion of DNA by restriction enzymes, and proteomic analyses of this phage. The isolated phage was capable of infecting a wide spectrum of enterococcal strains. The results of these investigations indicate that φ4D is similar to other Myoviridae bacteriophages (for example φEF24C), which have been successfully used in phagotherapy.
Insights
A novel bacteriophage, φ4D, was isolated and characterized for its potential as a therapeutic agent against Enterococcus faecalis infections. This virulent phage shows promise for phage therapy due to its broad host range and Myoviridae family characteristics.
Area of Science:
- Microbiology
- Virology
- Infectious Diseases
Background:
- Enterococcus faecalis is a significant cause of hospital-acquired infections.
- There is a critical need for new treatments against resistant bacterial strains.
- Bacteriophage therapy offers a promising alternative to antibiotics with a favorable safety profile.
Purpose of the Study:
- To isolate and characterize a novel virulent bacteriophage, named φ4D, from sewage.
- To evaluate the potential of φ4D as a therapeutic agent against Enterococcus faecalis.
Main Methods:
- Isolation and purification of bacteriophage φ4D from sewage.
- Electron microscopy for morphological characterization (head and tail dimensions).
- Pulsed-field gel electrophoresis for genome size estimation.
- Assays for latent period, burst size, host range, thermal stability, and proteomic analysis.
Main Results:
- φ4D exhibits Myoviridae morphology with an isometric head (74 ± 4 nm) and contractile tail (164 ± 4 nm).
- The phage genome size was estimated at 145 ± 2 kb.
- φ4D demonstrated a short latent period (25 min) and a burst size of 36 PFU/cell.
- The phage effectively infected a wide range of enterococcal strains.
Conclusions:
- The characterized bacteriophage φ4D is a virulent Myoviridae phage.
- φ4D shows potential for use in phage therapy against Enterococcus faecalis infections.
- Its properties are comparable to other Myoviridae phages successfully employed in therapeutic applications.
More Related Videos
Related Concept Videos
Viral Replication: Lytic Cycle
Lytic Cycle of Bacteriophages
DNA Bacteriophages
Lysogenic Cycle of Bacteriophages

